Earn CME with Engaging Sessions

 

The 2023 ACOG Annual Clinical & Scientific Meeting has long been a gathering of the leading experts in obstetrics and gynecology for sharing cutting-edge research, clinical best practices, and collaborative solutions to the challenges facing our community.

Accreditation for the 2023 Annual Clinical & Scientific Meeting

The American College of Obstetricians and Gynecologists (ACOG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. This live educational activity is designated for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

At the end of this activity, participants will be able to:

  • Discuss state-of-the-art research in obstetrics and gynecology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of obstetric and gynecologic disorders
  • Practice updated clinical skills for more effective diagnosis, management, and treatment of obstetric and gynecologic disorders and related sequelae
  • Apply updated knowledge and clinical skills in improving patient care
  • Construct new research questions based on updated scientific and clinical advances in obstetric and gynecologic-related disciplines
  • Facilitate interprofessional communication with the broader health care team to improve clinical decisions and patient outcomes

Target Audience

The ACOG Annual Clinical & Scientific Meeting is a scientific/medical conference designed for professionals, physicians, research scientists, and other professionals focused on improving obstetric and gynecologic care.

Statement of Independence

As a provider of continuing education, ACOG has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the ACOG Committee on Scientific Program (CSP) and ACOG Committee on Continuing Medical Education (CCME).

Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ACOG and to learners any financial relationship(s) that have occurred within the prior 24 months with any ineligible entities whose products are related to the continuing education content. Financial relationships are defined as remuneration in any amount from the ineligible entities in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ACOG has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following activity planning members reported financial relationship(s):

  • Jessica Kiley, MD
    Consultancy(ies): CVS
  • Mikio Albert Nihira, MD
    Consultancy(ies): Ethicon Legal, Hologic Educational, HealthTrust
  • Dikea Roussos-Ross, MD
    Consultancy(ies): SAGE Pharmaceuticals
    Speaker: MER CME
  • Andrea Denise Shields, MD, MS
    Member: Varda5, LLC

The following activity planning members reported no financial relationships:
Constance J. Bohon, MD, CSP Chair; Kenneth Hyun-Chung Kim, MD, CSP Chair Elect; Amy M. Autry, MD, CSP General Program Chair; Alson Burke, MD, CCME Chair; Stephen H. Bush, MD, CCME Vice Chair; Jocelynn L. Cook, PhD, MBA; Shontreal Monique Cooper, MD; Ryan Cuff, MD; Eve Duchesne, MEd; Nancy Fan, MD; Nagaraj Gabbur, MD; Katherine Glaser, MD; Melissa Hague, MD; Robert V. Higgins, MD; Susan Saadeldinlbrahim Khalil, MD; Monica Lutgendorf, MD; Melissa March, MD; Ryan C. McDonald, MD; Kathleen Morrell, MD, MPH; Jessian Louis Munoz, MD, PhD, MPH; Luke Newton, MD; Nicole Lee Plenty, MD; William Rayburn, MD; Nanette L. Rollene, MD; Francisco J. Ruiloba, MD; Kimberly A. Swan, MD; Lili Sheibani Wei, MD; Veronica Maria Pimentel, MD

All ACOG staff reported no relevant financial relationships.

Content Validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Disclaimers

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of ACOG.

Use of Professional Judgment

The educational content in this activity relates to basic principles of obstetric and gynecologic medicine and does not substitute for individual assessment based on the health care professional’s examination of the patient, laboratory data, and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and Dosages

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

Policy on Unlabeled/Off-Label Use

ACOG has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). ACOG requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Eligibility to Earn Continuing Education Credit

You must be registered for the Annual Clinical & Scientific Meeting* to be eligible to earn continuing education credit (AMA PRA Category 1 Credit™). CME certificates are provided to registered participants based on the successful completion of the activity, in its entirety, including the activity evaluation.

*Individuals registered as Guest/Spouse or Exhibitor are not eligible to earn credit for these sessions.

RELEASE DATE: May 19, 2023
EXPIRATION DATE: July 15, 2023 (date after which this activity is no longer certified for continuing medical education credit)

For questions regarding continuing education, please email education@acog.org.